CD274 and neoplasm: High-affinity NK (haNK) cells engineered NK-92 cells expressing endoplasmic reticulum-retained IL-2, with PD-L1 CAR effectively recognized and eliminated various tumor targets, including triple-negative breast cancer and lung, urogenital, gastric, and head and neck squamous cell carcinoma [66,135].